Bienville Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $283K | Hold |
|
|||||
|
2025
Q2 | $294K | Hold |
|
|||||
|
2025
Q1 | $307K | Hold |
|
|||||
|
2024
Q4 | $392K | Hold |
|
|||||
|
2024
Q3 | $383K | Hold |
|
|||||
|
2024
Q2 | $435K | Hold |
|
|||||
|
2024
Q1 | $579K | Hold |
|
|||||
|
2023
Q4 | $572K | Hold |
|
|||||
|
2023
Q3 | $444K | Buy |
|
|||||
|
2023
Q2 | $425K | Hold |
|
|||||
|
2023
Q1 | $379K | Hold |
|
|||||
|
2022
Q4 | $439K | Sell |
|
|||||
|
2022
Q3 | $648K | Buy |
|
|||||
|
2022
Q2 | $298K | Hold |
|
|||||
|
2022
Q1 | $262K | Hold |
|
|||||
|
2021
Q4 | $626K | Buy |
|